Targeted therapeutic interventions in liver cancer can be achieved by strategies that aim to modulate or restore TP53 function, which could lead to breakthroughs in treatment approaches for this complex malignancy (Farnebo et al., 2010). The gene discussed is TP53; the disease is liver cancer.